2.13
price up icon5.97%   0.12
after-market 시간 외 거래: 2.13
loading
전일 마감가:
$2.01
열려 있는:
$2.0291
하루 거래량:
342.25K
Relative Volume:
0.64
시가총액:
$191.72M
수익:
$7.05M
순이익/손실:
$-30.43M
주가수익비율:
-5.623
EPS:
-0.3788
순현금흐름:
$21.84M
1주 성능:
-1.39%
1개월 성능:
+19.66%
6개월 성능:
-22.26%
1년 성능:
+29.48%
1일 변동 폭
Value
$2.01
$2.13
1주일 범위
Value
$2.00
$2.5398
52주 변동 폭
Value
$1.07
$4.62

Proqr Therapeutics N V Stock (PRQR) Company Profile

Name
명칭
Proqr Therapeutics N V
Name
전화
-
Name
주소
-
Name
직원
166
Name
트위터
@proqr
Name
다음 수익 날짜
2025-03-14
Name
최신 SEC 제출 서류
Name
PRQR's Discussions on Twitter

PRQR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PRQR
Proqr Therapeutics N V
2.13 191.72M 7.05M -30.43M 21.84M -0.3788
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Proqr Therapeutics N V Stock (PRQR) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-29 재개 Cantor Fitzgerald Overweight
2025-04-29 개시 Evercore ISI Outperform
2025-03-10 업그레이드 Citigroup Neutral → Buy
2025-01-10 개시 Oppenheimer Outperform
2024-10-29 업그레이드 Raymond James Outperform → Strong Buy
2023-11-08 업그레이드 Chardan Capital Markets Neutral → Buy
2023-03-30 업그레이드 JMP Securities Mkt Perform → Mkt Outperform
2022-12-22 업그레이드 Cantor Fitzgerald Neutral → Overweight
2022-02-14 다운그레이드 Citigroup Buy → Neutral
2022-02-11 다운그레이드 Raymond James Strong Buy → Mkt Perform
2022-02-11 다운그레이드 Stifel Buy → Hold
2022-02-01 개시 Raymond James Strong Buy
2021-05-03 개시 Stifel Buy
2021-03-25 재확인 Citigroup Buy
2020-11-03 재개 Cantor Fitzgerald Overweight
2019-03-12 재확인 Chardan Capital Markets Buy
2018-12-19 개시 RBC Capital Mkts Outperform
2018-11-15 개시 Citigroup Buy
2018-09-19 개시 Evercore ISI Outperform
2017-09-26 재확인 JMP Securities Mkt Outperform
2016-06-20 개시 Chardan Capital Markets Neutral
2014-10-15 개시 Deutsche Bank Buy
2014-10-13 개시 H.C. Wainwright Buy
모두보기

Proqr Therapeutics N V 주식(PRQR)의 최신 뉴스

pulisher
Jun 15, 2025

Bank of America Corp DE Boosts Position in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

ProQR Therapeutics N.V. (NASDAQ:PRQR) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected - simplywall.st

Jun 13, 2025
pulisher
Jun 13, 2025

Equities Analysts Offer Predictions for PRQR FY2026 Earnings - MarketBeat

Jun 13, 2025
pulisher
Jun 11, 2025

Research Analysts Set Expectations for PRQR FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Buys Shares of 11,400 ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Analysts Set ProQR Therapeutics (NASDAQ:PRQR) Target Price at $8.00 - MarketBeat

Jun 09, 2025
pulisher
Jun 09, 2025

ProQR Therapeutics (NASDAQ:PRQR) Shares Sold by Two Sigma Advisers LP - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Investments LP Has $1.02 Million Stake in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

Jun 09, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Grows Position in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Two Sigma Investments LP Buys 320,614 Shares of ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

ProQR Therapeutics (NASDAQ:PRQR) Given Consensus Rating of “Buy” by Analysts - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

ProQR Therapeutics (NASDAQ:PRQR) Sees Significant Increase in Short Interest - MarketBeat

Jun 05, 2025
pulisher
Jun 03, 2025

ProQR Shareholders Approve Key Resolutions at Annual Meeting - TipRanks

Jun 03, 2025
pulisher
Jun 02, 2025

ProQR Therapeutics (NASDAQ:PRQR) Shares Purchased by Northern Trust Corp - MarketBeat

Jun 02, 2025
pulisher
May 31, 2025

Millennium Management LLC Grows Stock Position in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

May 31, 2025
pulisher
May 30, 2025

BNP Paribas Financial Markets Buys 15,900 Shares of ProQR Therapeutics (NASDAQ:PRQR) - Defense World

May 30, 2025
pulisher
May 29, 2025

Northern Trust Corp Has $1.11 Million Stock Holdings in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

May 29, 2025
pulisher
May 28, 2025

Woodline Partners LP Invests $9.43 Million in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

May 28, 2025
pulisher
May 27, 2025

Here's Why ProQR Therapeutics N.V.'s (NASDAQ:PRQR) CEO May Deserve A Raise - simplywall.st

May 27, 2025
pulisher
May 27, 2025

Millennium Management LLC Buys 2,683,351 Shares of ProQR Therapeutics (NASDAQ:PRQR) - Defense World

May 27, 2025
pulisher
May 25, 2025

Point72 Asset Management L.P. Buys New Position in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

May 25, 2025
pulisher
May 23, 2025

ProQR Therapeutics’ SWOT analysis: RNA editing pioneer’s stock faces pivotal year - Investing.com Canada

May 23, 2025
pulisher
May 19, 2025

Cantor Fitzgerald Issues Negative Forecast for PRQR Earnings - MarketBeat

May 19, 2025
pulisher
May 18, 2025

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Takes Position in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

May 18, 2025
pulisher
May 16, 2025

ProQR Therapeutics (NASDAQ:PRQR) Given Consensus Rating of "Buy" by Analysts - MarketBeat

May 16, 2025
pulisher
May 15, 2025

Oppenheimer Has Lowered Expectations for ProQR Therapeutics (NASDAQ:PRQR) Stock Price - Defense World

May 15, 2025
pulisher
May 15, 2025

Research Analysts Issue Forecasts for PRQR FY2025 Earnings - Defense World

May 15, 2025
pulisher
May 14, 2025

ProQR (PRQR) Price Target Cut by Oppenheimer Amid Clinical Updates | PRQR Stock News - GuruFocus

May 14, 2025
pulisher
May 13, 2025

DAFNA Capital Management LLC Buys 661,979 Shares of ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat

May 13, 2025
pulisher
May 13, 2025

ProQR Therapeutics (PRQR) Price Target Lowered by Oppenheimer | - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Oppenheimer Adjusts ProQR Therapeutics N.V Price Target to $9 From $15, Maintains Outperform Rating - marketscreener.com

May 13, 2025
pulisher
May 12, 2025

ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences - GlobeNewswire

May 12, 2025
pulisher
May 12, 2025

Raymond James Financial Inc. Invests $260,000 in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

May 12, 2025
pulisher
May 11, 2025

ProQR Therapeutics (NASDAQ:PRQR) Receives Average Recommendation of “Buy” from Analysts - Defense World

May 11, 2025
pulisher
May 09, 2025

ProQR: Q1 Earnings Snapshot - News-Times

May 09, 2025
pulisher
May 09, 2025

1,181,413 Shares in ProQR Therapeutics (NASDAQ:PRQR) Acquired by ArrowMark Colorado Holdings LLC - MarketBeat

May 09, 2025
pulisher
May 09, 2025

New Forecasts: Here's What Analysts Think The Future Holds For ProQR Therapeutics N.V. (NASDAQ:PRQR) - simplywall.st

May 09, 2025
pulisher
May 08, 2025

ProQR Therapeutics NV earnings missed, revenue topped estimates - Investing.com Australia

May 08, 2025
pulisher
May 08, 2025

ProQR Therapeutics NV earnings missed, revenue topped estimates By Investing.com - Investing.com Nigeria

May 08, 2025
pulisher
May 08, 2025

ProQR Therapeutics N.V. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025

Proqr Therapeutics N V (PRQR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):